Close Menu
The Cannabis Journal

    Subscribe to Updates

    Get the latest creative news from The Cannabis Journal

    What's Hot

    Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal

    September 29, 2025

    MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?

    September 26, 2025

    A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts

    September 23, 2025
    X (Twitter) Instagram
    The Cannabis JournalThe Cannabis Journal Monday, October 6
    Trending
    • Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal
    • MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?
    • A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts
    • Tilray and Sundial Growers Navigate Shifting Cannabis Landscape Amid Regulatory Optimism
    • The Value of REITs in a Dividend Portfolio: Spotlight on AGNC, Realty Income, and VICI
    • High Tide Poised for Strong Q3 Results After August Guidance — What to Watch
    • Klarna’s NYSE Debut: Europe’s BNPL Giant Eyes U.S. Expansion Amid Investor Buzz
    • Rescheduling Hope Ignites Buzz in Cannabis Industry — But Is the Optimism Warranted?
    The Cannabis JournalThe Cannabis Journal
    • Home
    • Cannabis News
    • Stocks
    • High Tide Inc.
    • About Us
    The Cannabis Journal
    Home»Cannabis News»High Tide Poised for Strong Q3 Results After August Guidance — What to Watch
    Cannabis News

    High Tide Poised for Strong Q3 Results After August Guidance — What to Watch

    The Cannabis JournalBy The Cannabis JournalSeptember 13, 2025No Comments7 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Calgary — September 13, 2025

    High Tide Inc. (Nasdaq: HITI; TSXV: HITI), the cannabis-retail and brand company behind the Canna Cabana chain and a growing white-label and global expansion initiative, is preparing to release its third fiscal quarter results on Monday, September 15, 2025 after market close, with a follow-up conference call on Tuesday morning. (hightideinc.com)

    The release follows a strong “sneak preview” of sorts in mid-August, when the company issued preliminary Q3 guidance. That preview has raised expectations among analysts and investors, and the actual numbers will be closely watched to see how closely the real-worlds results align with that guidance. Below is a look at what was shared in August, what it might mean, and what to watch for when the full report drops.


    August Guidance: Rising Bar for Q3

    On August 18, 2025, High Tide issued preliminary guidance for Q3 fiscal 2025 (the quarter ended July 31). Key points from that guidance included:

    • Record Revenue anticipated. The company expects that revenue in Q3 will surpass previous levels. (hightideinc.com)
    • Adjusted EBITDA to be ahead of analyst forecast. It’s not just revenue growth that’s expected; the profitability measure (adjusted for non-cash or non-core items) is predicted to show strong sequential improvement. (hightideinc.com)
    • Same-store sales growth of about 7.4% year-over-year. This is especially notable for the Canna Cabana retail network in Canada, and is described as the fastest in two years. (hightideinc.com)
    • The company also flagged its entry into Germany via an acquisition of a majority stake in Remexian Pharma GmbH, which indicates that growth is not solely domestic but increasingly international. (hightideinc.com)

    These previews suggest that High Tide is confident not only in top-line growth but also in its ability to convert that growth into improved operational performance.


    What This Means for High Tide: Implications & Expectations

    The August guidance sets a fairly aggressive benchmark. If High Tide delivers on those expectations, several positive implications follow:

    1. Reinforced Credibility and Momentum
      Matching or exceeding guidance would underscore High Tide’s ability to execute consistently, particularly in same-store sales and managed profitability. This would strengthen investor confidence.
    2. Strong Retail Base
      The same-store sales metric is often a key indicator in retail businesses that growth is coming from existing operations rather than just expansion. That 7.4% number suggests that the core Canna Cabana stores are showing robust demand.
    3. Margin & Efficiency Gains
      With adjusted EBITDA expected to be ahead of forecasts, the company must be controlling costs, achieving scale, or realizing synergies. If margins improve, it could indicate better leverage from its infrastructure or better mix (higher-margin products, more sales per store, efficiencies in supply chain).
    4. International Growth as a Dilutive or Accretive Factor
      The move into Germany via Remexian Pharma is important. It could become an additional revenue stream, but there are integration risks—regulatory, cost, competition. How that shows up (or not) in the Q3 numbers will matter for long-term growth narrative.
    5. Investor Expectations are Elevated
      Because the guidance was strong, the expectations are elevated. If the results fall short of guidance in a material way, the stock may react negatively. Conversely, beating guidance could lead to a positive re-rating.

    What Already Known: Q1 & Q2 Trends

    To put the Q3 preview in context, it’s useful to remember what High Tide had shown in recent quarters:

    • Q1 2025: Revenue of CAD$142.5 million, up ~11% year-over-year; same-store sales increased ~5% YoY; strong growth in loyalty programs (Cabana Club & ELITE). (PR Newswire)
    • Q2 2025: Revenue ~CAD$137.8 million, up ~11% YoY (faster growth when adjusted for fewer days); adjusted EBITDA positive; free cash flow of around CAD$4.9 million. Retail growth strong; expansion in memberships; negotiations underway for German medical cannabis entry. (hightideinc.com)

    These trends suggest that the company has already established momentum in both revenue and retail execution, which makes the Q3 guidance more credible.


    What to Watch in the Q3 Report

    Given the prior data and the August preview, here are some of the key metrics and statements investors will be looking out for when the Q3 results are released:

    Metric / ElementWhy It Matters
    Revenue vs. GuidanceWill show if projected record revenue was achieved. If revenue is below the guided level, it may suggest weak spots.
    Adjusted EBITDA & Margin TrendsThis reveals whether revenue growth is translating into real profitability gains. Margin pressures (e.g., cost increases, inflation, supply chain) could undermine adjusted EBITDA.
    Same-Store Sales GrowthThe 7.4% figure is ambitious; beating or meeting it shows strong demand, good execution. Falling below could signal issues in consumer environment or competition.
    Cash Flow / Free Cash FlowInvestors will want to see whether operations are generating cash, especially since Q2 had positive free cash flow (~CAD$4.9M), but that number can fluctuate. Strong cash flow supports debt servicing, further store expansion, etc. (hightideinc.com)
    Retail Footprint Growth / Store CountAny increase in store opens or closings will show how physical expansion is contributing. Also, inclusion of any German operations or other international components.
    Membership / Loyalty MetricsGrowth of Cabana Club and ELITE membership is a recurring theme. More members generally mean more repeat business and revenue stability.
    Update on Germany / Remexian AcquisitionHow much in near term the Germany operations will contribute, what costs or integration issues are present. Also regulatory environment.
    Expense Pressures / Cost ControlWages, real estate, supply chain, regulatory compliance costs can squeeze margins; whether management addresses these or gives guidance on them.
    Outlook and Forward GuidanceWhat the company says about Q4 or full-year, and whether they adjust expectations given macro conditions (inflation, regulatory changes).

    Risks & Things That Could Go Wrong

    While the August guidance suggests bullish expectations, there are always potential headwinds:

    • Regulatory Uncertainty in international markets, especially Germany. Cannabis regulatory regimes are complex; changes or delays could affect expected contributions.
    • Cost Pressures: Labour, rent, supply chain, utilities, etc., could increase faster than revenue growth, squeezing margins even if revenue is good.
    • Macro Factors: Consumer spending, inflation, interest rates, competition may all weigh.
    • Cannabis-specific Risks: Licensing, regulatory delays, supply restrictions, tax or compliance burdens.
    • Currency / Cross-Border Issues: As operations become more global, exchange rate swings, import/export costs, etc., matter.

    Analyst Take / Market Expectations

    From the external research and reporting:

    • Some analyst commentary (e.g., in Seeking Alpha) suggests that High Tide’s Germany deal is accretive and that “good Q3 momentum” is expected. (Seeking Alpha)
    • The “record revenue, adjusted EBITDA ahead of analyst forecasts, and the best same-store growth in two years” language in the August preview sets the bar high and may mean that even a small underperformance might be viewed as a disappointment. (hightideinc.com)

    What to Expect When the Results Drop

    Given all of the above, here are plausible scenarios for Q3:

    Base Case
    High Tide meets or slightly exceeds its guidance: revenue hits a record level (fairly likely given retail strength), same-store sales around 7-8% YoY, adjusted EBITDA grows both absolutely and as a margin %. Free cash flow may improve over Q2. Germany contribution is modest but positive or establishing. Expect guidance for Q4 or full year to be reaffirmed or fine-tuned upward if momentum continues.

    Upside Case
    If demand is stronger than expected, or cost controls are tighter, High Tide could beat its own guidance. Perhaps same-store sales exceed 8%, adjusted EBITDA margin expands more than forecast, and the Germany acquisition begins contributing revenue earlier. Loyalty program growth could accelerate, giving more recurring revenue. This would likely pleasantly surprise investors.

    Downside Case
    Revenue misses slightly (e.g. weaker consumer traffic, increased competition), same-store sales come in a bit under 7.4%, and adjusted EBITDA comes below analysts’ forecasts due to margin compression. Free cash flow might be weak or negative, especially if there are write-downs or one-off costs related to expansion or Germany entry. In that case, market reaction could be negative, with pressure on forward guidance and possibly share price.


    Bottom Line: What to Know Going in

    As High Tide readies its Q3 numbers, investors have reason for cautious optimism. The August preview sets a strong tone: revenue growth, expanding operations, and improved profitability. But execution will matter — can High Tide convert its operational gains (same-store sales, membership growth, retail strength) into bottom-line results, especially in terms of adjusted EBITDA and free cash flow?

    All eyes will be on whether the company can keep momentum, manage costs, and prove that its international moves (notably into Germany) are more than just announcements, but real value drivers. The report on September 15 (after market close) and the conference call on September 16 should offer clarity on these issues. (hightideinc.com)

    cannabis cannabis market Catalyst High Tide stocks
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleKlarna’s NYSE Debut: Europe’s BNPL Giant Eyes U.S. Expansion Amid Investor Buzz
    Next Article The Value of REITs in a Dividend Portfolio: Spotlight on AGNC, Realty Income, and VICI
    The Cannabis Journal
    • Website

    Related Posts

    Cannabis News

    Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal

    September 29, 2025
    Cannabis News

    MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?

    September 26, 2025
    Companies

    A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts

    September 23, 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Latest

    Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal

    September 29, 20255 Views

    MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?

    September 26, 20252 Views

    A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts

    September 23, 20251 Views

    Tilray and Sundial Growers Navigate Shifting Cannabis Landscape Amid Regulatory Optimism

    September 17, 20255 Views
    Stay In Touch
    • Twitter
    • Instagram

    Subscribe to Updates

    Get the latest tech news from The Cannabis Journal.

    Most Popular

    High Tide Surges Ahead as Integrity and Scale Define Industry Leadership

    September 4, 20259 Views

    Tilray Stock: Stunning 5x Growth Potential Revealed

    August 26, 20258 Views

    German Retail Acquisition Pending for High Tide – New Cannabis Ventures

    August 21, 20258 Views
    Our Picks

    Trump’s Truth Social Post Sparks Buzz — Enthusiasts See New Signal

    September 29, 2025

    MMJ’s Cannabis Softgel Approach Offers a New Path in Huntington’s Disease — Scalable Alternative to Gene Therapy?

    September 26, 2025

    A New Alliance: Nvidia Invests in Intel Amidst Geopolitical Shifts

    September 23, 2025

    Subscribe to Updates

    Get the latest creative news from The Cannabis Journal

    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms & Conditions
    • Disclaimer
    © 2025 ThemeSphere. Designed by ThemeSphere.

    Type above and press Enter to search. Press Esc to cancel.

    Ad Blocker Enabled!
    Ad Blocker Enabled!
    To make it possible to run this website, we would love to show you some ads! Please <3 Thanks - The Cannabis Journal